Stay updated with breaking news from Heca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/4UYHK7HFCVMTPGSODQ6LHKMFYU.jpg)
Scientific journal Nature on Wednesday said a personalised treatment based on messenger RNA by BioNTech potentially bodes well for the future of fighting an extremely aggressive form of cancer after the regimen was shown to trigger a promising immune reaction in some pancreatic cancer patients.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XDLS6UMELVMWPL6SDAXL7CAI2I.jpg)
The U.S. Food and Drug Administration's staff reviewers raised concerns over limited data on Sarepta Therapeutics Inc's gene therapy for a muscle-wasting disorder, ahead of a meeting of the agency's advisers on Friday.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3NCMH4R365JZ7BUMDFBJMRLABM.jpg)
The U.S. government on Thursday will end the COVID-19 Public Health Emergency that allowed millions of Americans to receive vaccines, tests and treatments at no cost.
Shares of Manforce condom maker Mankind Pharma Ltd surged as much as 31% in debut trading on Tuesday, valuing the company at 566.43 billion rupees ($6.93 billion) in the country's biggest listing so far this year.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BGUJNTECV5I7VPALKQTTWYKE5A.jpg)
Fresenius Medical Care said on Tuesday labour shortages were slowly easing as the German dialysis specialist reported a drop in first-quarter adjusted operating income that was not as steep as some analysts had expected.